IBDEI0NO ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10655,1,4,0)
 ;;=4^F32.3
 ;;^UTILITY(U,$J,358.3,10655,2)
 ;;=^5003524
 ;;^UTILITY(U,$J,358.3,10656,0)
 ;;=F33.9^^42^473^12
 ;;^UTILITY(U,$J,358.3,10656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10656,1,3,0)
 ;;=3^MDD,Recurrent Episode,Unspec
 ;;^UTILITY(U,$J,358.3,10656,1,4,0)
 ;;=4^F33.9
 ;;^UTILITY(U,$J,358.3,10656,2)
 ;;=^5003537
 ;;^UTILITY(U,$J,358.3,10657,0)
 ;;=F33.0^^42^473^9
 ;;^UTILITY(U,$J,358.3,10657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10657,1,3,0)
 ;;=3^MDD,Recurrent Episode,Mild
 ;;^UTILITY(U,$J,358.3,10657,1,4,0)
 ;;=4^F33.0
 ;;^UTILITY(U,$J,358.3,10657,2)
 ;;=^5003529
 ;;^UTILITY(U,$J,358.3,10658,0)
 ;;=F33.1^^42^473^10
 ;;^UTILITY(U,$J,358.3,10658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10658,1,3,0)
 ;;=3^MDD,Recurrent Episode,Moderate
 ;;^UTILITY(U,$J,358.3,10658,1,4,0)
 ;;=4^F33.1
 ;;^UTILITY(U,$J,358.3,10658,2)
 ;;=^5003530
 ;;^UTILITY(U,$J,358.3,10659,0)
 ;;=F33.2^^42^473^11
 ;;^UTILITY(U,$J,358.3,10659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10659,1,3,0)
 ;;=3^MDD,Recurrent Episode,Severe
 ;;^UTILITY(U,$J,358.3,10659,1,4,0)
 ;;=4^F33.2
 ;;^UTILITY(U,$J,358.3,10659,2)
 ;;=^5003531
 ;;^UTILITY(U,$J,358.3,10660,0)
 ;;=F33.3^^42^473^6
 ;;^UTILITY(U,$J,358.3,10660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10660,1,3,0)
 ;;=3^MDD,Recurrent Episode w/ Psychotic Features
 ;;^UTILITY(U,$J,358.3,10660,1,4,0)
 ;;=4^F33.3
 ;;^UTILITY(U,$J,358.3,10660,2)
 ;;=^5003532
 ;;^UTILITY(U,$J,358.3,10661,0)
 ;;=F33.41^^42^473^8
 ;;^UTILITY(U,$J,358.3,10661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10661,1,3,0)
 ;;=3^MDD,Recurrent Episode,In Partial Remission
 ;;^UTILITY(U,$J,358.3,10661,1,4,0)
 ;;=4^F33.41
 ;;^UTILITY(U,$J,358.3,10661,2)
 ;;=^5003534
 ;;^UTILITY(U,$J,358.3,10662,0)
 ;;=F33.42^^42^473^7
 ;;^UTILITY(U,$J,358.3,10662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10662,1,3,0)
 ;;=3^MDD,Recurrent Episode,In Full Remission
 ;;^UTILITY(U,$J,358.3,10662,1,4,0)
 ;;=4^F33.42
 ;;^UTILITY(U,$J,358.3,10662,2)
 ;;=^5003535
 ;;^UTILITY(U,$J,358.3,10663,0)
 ;;=F34.1^^42^473^19
 ;;^UTILITY(U,$J,358.3,10663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10663,1,3,0)
 ;;=3^Persistent Depressive Disorder (Dysthmia)
 ;;^UTILITY(U,$J,358.3,10663,1,4,0)
 ;;=4^F34.1
 ;;^UTILITY(U,$J,358.3,10663,2)
 ;;=^331913
 ;;^UTILITY(U,$J,358.3,10664,0)
 ;;=N94.3^^42^473^20
 ;;^UTILITY(U,$J,358.3,10664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10664,1,3,0)
 ;;=3^Premenstrual Dysphoric Disorder
 ;;^UTILITY(U,$J,358.3,10664,1,4,0)
 ;;=4^N94.3
 ;;^UTILITY(U,$J,358.3,10664,2)
 ;;=^5015919
 ;;^UTILITY(U,$J,358.3,10665,0)
 ;;=F06.34^^42^473^3
 ;;^UTILITY(U,$J,358.3,10665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10665,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Mixed Features,Unsp
 ;;^UTILITY(U,$J,358.3,10665,1,4,0)
 ;;=4^F06.34
 ;;^UTILITY(U,$J,358.3,10665,2)
 ;;=^5003060
 ;;^UTILITY(U,$J,358.3,10666,0)
 ;;=F32.89^^42^473^4
 ;;^UTILITY(U,$J,358.3,10666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10666,1,3,0)
 ;;=3^Depressive Disorder,Other Specified
 ;;^UTILITY(U,$J,358.3,10666,1,4,0)
 ;;=4^F32.89
 ;;^UTILITY(U,$J,358.3,10666,2)
 ;;=^5138442
 ;;^UTILITY(U,$J,358.3,10667,0)
 ;;=F34.81^^42^473^5
 ;;^UTILITY(U,$J,358.3,10667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10667,1,3,0)
 ;;=3^Disruptive Mood Dysregulation Disorder
 ;;^UTILITY(U,$J,358.3,10667,1,4,0)
 ;;=4^F34.81
